APC Restore supports antigen-presenting cell function through coordinated autophagy, mitochondrial renewal, and immune regulation—addressing interconnected systems rather than a single pathway.
Why APC Restore is different
-
Targets upstream immune dysfunction at the level of antigen-presenting cells
-
Combines autophagy, mitochondrial, and immune support
-
Designed as a system, not a single-pathway supplement
What to expect
-
Gradual improvements in energy and resilience
-
Reduced post-exertional crashes over time
-
More stable immune and autonomic responses
This is not a general wellness supplement—it is a targeted approach for complex, system-level dysfunction.
Mechanisms of Action
On restoration
Resolving illness is not simply a matter of eradication, but restoration of function. In Chinese medicine, recovery is achieved through regulation—restoring the body’s capacity to respond, adapt, and maintain balance. We are living systems that require support, coherence, and repair.
What APC Restore is designed to do
APC Restore was developed from the framework of Lingering Pathogenic Illness (LPI), which describes chronic conditions that persist after immune disruption.
Rather than stimulating immunity, this formula is designed to stabilize immune signaling under metabolic stress—particularly at the level of antigen-presenting cells (APCs), which coordinate immune recognition and response.
In many chronic conditions, these cells lose functional flexibility, becoming vulnerable to oxidative stress, impaired signaling, and disrupted energy metabolism. APC Restore is designed to support this upstream layer of immune function.
A systems-level approach
This formulation integrates three core domains:
-
Autophagy and cellular renewal — supports mitochondrial quality control (spermidine, Urolithin A)
-
Mitochondrial and metabolic function — supports energy production and redox balance (oxaloacetate, ALCAR, taurine, dihydroberberine)
-
Immune regulation and signaling — supports coordinated immune communication under stress (glutathione, trace minerals, botanical compounds)
Botanical and circulatory support
The botanical matrix, including Ling Zhi (Ganoderma), Dan Shen, Wu Wei Zi, Bai Zhu, and others, supports qi, regulates defensive function, and modulates inflammatory tone without overstimulation.
Lumbrokinase supports microcirculatory flow, an important factor in immune trafficking and tissue-level signaling.
Important considerations
Lumbrokinase is a fibrinolytic enzyme and may have additive effects with anticoagulant medications.
Not recommended during pregnancy or nursing.
Concerns and Hopes
Cures, in a broad sense, do not exist nor are they what marketing companies claim them to be. "Cures" enable aspects of capitalist and eugenic culture designed to make money only to leave others behind as seen in the global response to COVID-19.
More and more research is warning of progressive neurodegenerative disease after COVID-19. If you haven't already, consider applying for disability subsidies in your country if you qualify and/or if your ability to provide for yourself has changed or become unpredictable because of COVID-19.
.png)
Metabolic / Mitochondrial / Redox Imbalance:
↓arginine, ↑ornithine/citrulline ratio
(↑ammonia, ↑lactate, ↓NO)
(Redox State Imbalance, ↓NAD+)
(Warburg Effect)
↑amino/hepatic gluconeogenisis
(glucose resistance, dysregulated glucose-alanine cycle, →muscle breakdown)
HHV / EBV / HERV-W Activation:
↑kynurenic acid ↑syncytin-1 ↑DUX4 ↑fibronectin (↑clotting, ↑neoplasms)
All underlined text above links to correlating citations.
*Metabolome findings based on https://www.medrxiv.org/content/10.1101/2023.05.03.23289456v1.full.pdf
López-Hernández, Yamilé, et al. “The Plasma Metabolome of Long COVID-19 Patients Two Years after Infection.” medRxiv, 1 Jan. 2023, www.medrxiv.org/content/10.1101/2023.05.03.23289456v1
Davis, Hannah E., et al. “Long Covid: Major Findings, Mechanisms and Recommendations.” Nature News, 13 Jan. 2023, www.nature.com/articles/s41579-022-00846-2
Babalghith, Ahmad O., et al. “The Role of Berberine in Covid-19: Potential Adjunct Therapy - Inflammopharmacology.” SpringerLink, 2 Oct. 2022, link.springer.com/article/10.1007/s10787-022-01080-1
Schaffer, Stephen, and Ha Won Kim. “Effects and Mechanisms of Taurine as a Therapeutic Agent.” Biomolecules & Therapeutics, 1
May 2018, www.ncbi.nlm.nih.gov/pmc/articles/PMC5933890/
Schaffer, Stephen W., et al. “Differences between Physiological and Pharmacological Actions of Taurine.” Advances in Experimental edicine and Biology, July 2022, link.springer.com/chapter/10.1007/978-3-030-93337-1_30
Seidel, Huebbe, and Rimbach. “Taurine: A Regulator of Cellular Redox Homeostasis and Skeletal Muscle Function.” Molecular Nutrition & Food Research, August 2019, pubmed.ncbi.nlm.nih.gov/30211983/
Jong, Sandal, and Schaffer. “The Role of Taurine in Mitochondria Health: More than Just an Antioxidant.” Molecules (Basel, Switzerland), August 2021, pubmed.ncbi.nlm.nih.gov/34443494/
Michalk, Wingenfeld, et al. “The Mechanisms of Taurine Mediated Protection against Cell Damage Induced by Hypoxia and Reoxygenation.” Advances in Experimental Medicine and Biology, pubmed.ncbi.nlm.nih.gov/8915359/. Accessed 21 May 2023.
Anis, and Zaky. "Glutamine and Taurine: No Longer Supplementary Nutrients." Journal of Anaesthesiology, January 2013, www.researchgate.net/publication/343323133_Glutamine_and_taurine_no_longer_supplementary_nutrients
Zhang, Pengcheng, et al. “Berberine Inhibits Growth of Liver Cancer Cells by Suppressing Glutamine Uptake.” OncoTargets and Therapy, 31 Dec. 2019, www.ncbi.nlm.nih.gov/pmc/articles/PMC6978679/
Combs, McClurg. “Sarcosine Dehydrogenase.” Sarcosine Dehydrogenase - an Overview | ScienceDirect Topics, The Vitamins(Sixth Edition), 2022, www.sciencedirect.com/topics/nursing-and-health-professions/sarcosine-dehydrogenase
Walter, Fruzsina R., et al. “Blood–Brain Barrier Dysfunction in L-Ornithine Induced Acute Pancreatitis in Rats and the Direct Effect of L-Ornithine on Cultured Brain Endothelial Cells - Fluids and Barriers of the CNS.” BioMed Central, 17 Feb. 2022, fluidsbarrierscns.biomedcentral.com/articles/10.1186/s12987-022-00308-0
Ou, Xiaofeng, et al. “Cognitive Impairments Induced by Severe Acute Pancreatitis Are Attenuated by Berberine Treatment in Rats.” Molecular Medicine Reports, 1 Sept. 2018, www.spandidos-publications.com/10.3892/mmr.2018.9313
Li, Jie, et al. “Berberine Inhibits the Warburg Effect through Tet3/Mir-145/HK2 Pathways in Ovarian Cancer Cells.” Journal of Cancer, 1 Jan. 2021, www.jcancer.org/v12p0207.htm
Almani, Suhail Ahmed, et al. “Berberine Protects against Metformin-Associated Lactic Acidosis in Induced Diabetes Mellitus.” Iranian Journal of Basic Medical Sciences, May 2017, www.ncbi.nlm.nih.gov/pmc/articles/PMC5478779/
Aiyun Li a, et al. “Berberine Reduces Pyruvate-Driven Hepatic Glucose Production by Limiting Mitochondrial Import of Pyruvate through Mitochondrial Pyruvate Carrier 1.” EBioMedicine, 6 Aug. 2018, www.sciencedirect.com/science/article/pii/S2352396418302858
Guo, Wei, et al. “Glutamic-Pyruvic Transaminase 1 Facilitates Alternative Fuels for Hepatocellular Carcinoma Growth-a Small Molecule Inhibitor, Berberine.” MDPI, 9 July 2020, www.mdpi.com/2072-6694/12/7/1854
Ishikura, Keisuke, et al. “Effect of Taurine Supplementation on the Alterations in Amino Acid Content in Skeletal Muscle with Exercise in Rat.” Journal of Sports Science & Medicine, 1 June 2011, www.ncbi.nlm.nih.gov/pmc/articles/PMC3761861/
Sun, Runbin, et al. “The Hypoglycemic Effect of Berberine and Berberrubine Involves Modulation of Intestinal Farnesoid X Receptor Signaling Pathway and Inhibition of Hepatic Gluconeogenesis.” Drug Metabolism & Disposition, 1 Mar. 2021, dmd.aspetjournals.org/content/49/3/276.abstract
Yu, Y., et al. “Berberine Improves Cognitive Deficiency and Muscular Dysfunction via Activation of the AMPK/SIRT1/PGC-1A Pathway in Skeletal Muscle from Naturally Aging Rats - The Journal of Nutrition, Health & Aging.” SpringerLink, 6 Mar. 2018, link.springer.com/article/10.1007/s12603-018-1015-7
Kosalec, Ivan, et al. “The Spectrum of Berberine Antibacterial and Antifungal Activities.” SpringerLink, 3 Feb. 2022, link.springer.com/chapter/10.1007/978-3-030-83504-0_7
Li, Jiaojiao, Pin Meng, et al. “Effect of Berberine Hydrochloride on the Diversity of Intestinal Flora in Parkinson’s Disease Patients.” Contrast Media & Molecular Imaging, 30 May 2022, www.ncbi.nlm.nih.gov/pmc/articles/PMC9170458
Duszka, Kalina. “Versatile Triad Alliance: Bile Acid, Taurine and Microbiota.” MDPI, 29 July 2022, www.mdpi.com/2073-4409/11/15/2337
Fu, Ni, Wang, Fu, and Hong. “Berberine Suppresses Mast Cell-Mediated Allergic Responses via Regulating Fcɛri-Mediated and MAPK Signaling.” International Immunopharmacology, March 2019, pubmed.ncbi.nlm.nih.gov/30861392/
McCarty, Mark F, et al. “Nutraceutical Aid for Allergies - Strategies for down-Regulating Mast Cell Degranulation.” Journal of Asthma and Allergy, 27 Oct. 2021, www.ncbi.nlm.nih.gov/pmc/articles/PMC8558634/
Tanikawa, Kiba, Yu, et al. “Degradative Effect of Nattokinase on Spike Protein of SARS-COV-2.” Molecules (Basel, Switzerland), August 2022, pubmed.ncbi.nlm.nih.gov/36080170/
Bhat, Mujtaba Aamir, et al. “Expedition into Taurine Biology: Structural Insights and Therapeutic Perspective of Taurine in Neurodegenerative Diseases.” Biomolecules, 5 June 2020, www.ncbi.nlm.nih.gov/pmc/articles/PMC7355587/
Tavaf, Soltanmohammadi, et al. "Berberine promotes immunological outcomes and decreases neuroinflammation in the experimental model of multiple sclerosis through the expansion of Treg and Th2 cells." - Wiley Online Library, January 2023, onlinelibrary.wiley.com/doi/10.1002/iid3.766
Warowicka, Alicja, et al. “Antiviral Activity of Berberine.” Archives of Virology, Sept. 2020, www.ncbi.nlm.nih.gov/pmc/articles/PMC7320912/
Šudomová, Miroslava, et al. “Berberine in Human Oncogenic Herpesvirus Infections and Their Linked Cancers.” Viruses, 28 May 2021, www.ncbi.nlm.nih.gov/pmc/articles/PMC8229678/
Wang, Kening, et al. “Glutamine Supplementation Suppresses Herpes Simplex Virus Reactivation.” The Journal of Clinical Investigation, 30 June 2017, www.ncbi.nlm.nih.gov/pmc/articles/PMC5490748/
Huang, Kaipeng, et al. “Berberine Reduces Fibronectin Expression by Suppressing the S1P-S1P2 Receptor Pathway in Experimental Diabetic Nephropathy Models.” PLOS ONE, journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0043874
Ciszewski, Lu-Nguyen, Slater, et al. “G-Quadruplex Ligands Mediate Downregulation of DUX4 Expression.” Nucleic Acids Research, pubmed.ncbi.nlm.nih.gov/32182342/
Ma, Shu-Rong, et al. “Berberine Treats Atherosclerosis via a Vitamine-like Effect down-Regulating Choline-TMA-TMAO Production Pathway in Gut Microbiota.” Nature News, 7 July 2022, www.nature.com/articles/s41392-022-01027-6
Zheng, Zhihua, et al. “Identification of Berberine as a Potential Therapeutic Strategy for Kidney Clear Cell Carcinoma and COVID-19 Based on Analysis of Large-Scale Datasets.” Frontiers in Immunology, 23 Mar. 2023, www.ncbi.nlm.nih.gov/pmc/articles/PMC10076552/
Gibellini, Lara, et al. “Altered Bioenergetics and Mitochondrial Dysfunction of Monocytes in Patients with Covid-19 Pneumonia.” EMBO Molecular Medicine, 7 Dec. 2020, www.ncbi.nlm.nih.gov/pmc/articles/PMC7645870/
Wang, Zhao, et al. "Effect of Taurine on Leucocyte Function" - European Journal of Pharmacology, June 2009, www.researchgate.net/publication/223078816_Effect_of_taurine_on_leucocyte_function
Yuhan Zhang, et al. “Berberine for Bone Regeneration: Therapeutic Potential and Molecular Mechanisms.” Journal of Ethnopharmacology, 29 May 2021, www.sciencedirect.com/science/article/abs/pii/S0378874121004761#:~:text=Berberine%20promotes%20osteogenesis,mineralization%20to%20promote%20bone%20formation
Zhu, Xiaofei, et al. “The Mitohormetic Response as Part of the Cytoprotection Mechanism of Berberine - Molecular Medicine.” BioMed Central, 23 Jan. 2020, molmed.biomedcentral.com/articles/10.1186/s10020-020-0136-8